EXACT THERAPEUTICS AS

0581 OSLO

Finances

Share Ownership

Return on Equity

−61,6 %

Current Ratio

4,81

Debt-to-Equity Ratio

0,02

Key figures (NOK)	2022	2021	2020	2019
Revenue	455 000	52 000	0	7 428 000
Net Income	−40 104 000	−58 590 000	−33 085 000	−14 982 000
Total Assets	82 508 000	117 627 000	170 233 000	51 762 000
Total Equity	65 108 000	105 741 000	159 654 000	42 079 000

Income (NOK)	2022	2021	2020	2019
Revenue	455 000	52 000	0	7 428 000
Expenditure	41 229 000	59 163 000	34 698 000	23 408 000
Operating Profit	−40 775 000	−59 111 000	−34 699 000	−15 980 000
Financial Income	1 013 000	959 000	1 773 000	1 070 000
Financial Costs	805 000	439 000	160 000	72 000
Financial Balance	208 000	520 000	1 613 000	998 000
Earnings Before Tax	−40 566 000	−58 590 000	−33 085 000	−14 982 000
Tax	−462 000	0	0	0
Net Income	−40 104 000	−58 590 000	−33 085 000	−14 982 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	4 974 000	6 331 000	4 518 000	1 287 000
Total Current Assets	77 533 000	111 296 000	165 715 000	50 475 000
Total Assets	82 508 000	117 627 000	170 233 000	51 762 000
Total Retained Equity	−40 143 000	−122 015 000	−63 452 000	−30 452 000
Total Equity	65 108 000	105 741 000	159 654 000	42 079 000
Total Long-Term Debt	1 274 000	1 352 000	0	0
Total Current Debt	16 126 000	10 535 000	10 579 000	9 683 000
Total Equity and Debt	82 508 000	117 627 000	170 233 000	51 762 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	52 000	0	88 000
Other Income	455 000	0	0	7 340 000
Revenue	455 000	52 000	0	7 428 000
Cost of Goods Sold	0	0	0	0
Salary Costs	14 116 000	17 990 000	17 558 000	7 363 000
Depreciation	2 003 000	1 817 000	1 078 000	284 000
Impairment	0	0	0	0
Expenditure	41 229 000	59 163 000	34 698 000	23 408 000
Operating Profit	−40 775 000	−59 111 000	−34 699 000	−15 980 000
Financial Income	1 013 000	959 000	1 773 000	1 070 000
Financial Costs	805 000	439 000	160 000	72 000
Financial Balance	208 000	520 000	1 613 000	998 000
Dividends	0	0	0	0
Net Income	−40 104 000	−58 590 000	−33 085 000	−14 982 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	4 974 000	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	6 331 000	4 518 000	1 287 000
Total Tangible Assets	4 974 000	6 331 000	4 518 000	1 287 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	4 974 000	6 331 000	4 518 000	1 287 000
Stock	0	0	0	0
Total Investments	0	20 776 000	20 499 000	21 629 000
Cash, Bank	69 390 000	82 911 000	139 224 000	23 755 000
Total Current Assets	77 533 000	111 296 000	165 715 000	50 475 000
Total Assets	82 508 000	117 627 000	170 233 000	51 762 000
Total Equity	65 108 000	105 741 000	159 654 000	42 079 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	1 274 000	1 352 000	0	0
Creditors	15 630 000	0	0	3 341 000
Unpaid Taxes	0	0	0	852 000
Dividends	0	0	0	0
Other Current Debt	496 000	10 535 000	10 579 000	5 491 000
Total Current Debt	16 126 000	10 535 000	10 579 000	9 683 000
Total Equity and Debt	82 508 000	117 627 000	170 233 000	51 762 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−61,6 %	−55,41 %	−20,72 %	−35,6 %
Debt-to-Equity Ratio	0,02	0,01	0	0
Operating Profit Margin	−8 961,54 %	−113 675 %	-	−215,13 %
Current Ratio	4,81	10,56	15,66	5,21
Quick Ratio	4,81	10,56	15,66	5,21
Equity Ratio	0,79	0,9	0,94	0,81
Gross Profit Margin	100 %	100 %	-	100 %